Related Experiment Video

Updated: Jul 15, 2025

In Vitro Transcription Assays and Their Application in Drug Discovery
09:28

In Vitro Transcription Assays and Their Application in Drug Discovery

Published on: September 20, 2016

15.2K

Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile

Rusha Pal1, Mohamed N Seleem1,2

  • 1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University , Blacksburg, Virginia, USA.

Microbiology Spectrum
|September 29, 2023
PubMed
Abstract

Insights

Peptide nucleic acids (PNAs) offer a novel approach to combat Clostridioides difficile infections by targeting the essential rpoA gene. This method effectively inhibits pathogen growth and reduces virulence without harming beneficial gut bacteria.

Area of Science:

  • Microbiology
  • Antimicrobial Therapeutics
  • Molecular Biology

Background:

  • Clostridioides difficile infection (CDI) is a significant cause of antibiotic-associated diarrhea.
  • Current antibiotic therapies for CDI can disrupt gut microbiome homeostasis, leading to recurrent infections.
  • Novel therapeutic strategies are needed to address the limitations of existing treatments.

Purpose of the Study:

  • To investigate the potential of peptide nucleic acids (PNAs) as a targeted therapeutic agent against C. difficile.
  • To evaluate the efficacy of a novel PNA construct targeting the RNA polymerase alpha subunit (rpoA) gene in C. difficile.

Main Methods:

  • Design and synthesis of a PNA construct targeting the C. difficile rpoA gene.
  • Assessment of PNA's inhibitory and bactericidal activity against clinical C. difficile isolates.
  • Evaluation of PNA's effect on the expression of virulence factors (tcdA, tcdB) and sporulation gene (spoOA).
  • Testing PNA efficacy under varying pH conditions and against high pathogen inoculums.
  • Assessing PNA specificity against beneficial gut microflora.

Main Results:

  • The designed anti-rpoA PNA construct demonstrated inhibitory activity against clinical C. difficile isolates with minimum inhibitory concentrations between 4 and 8 µM.
  • The PNA exhibited bactericidal activity and suppressed the expression of key virulence genes (tcdA, tcdB) and the sporulation gene (spoOA).
  • PNA efficacy remained consistent across different pH levels and high pathogen loads.
  • The PNA conjugate showed high specificity for C. difficile, with no inhibition of beneficial gut microflora.

Conclusions:

  • The rpoA gene represents a promising therapeutic target for narrow-spectrum treatment of C. difficile infections.
  • PNA-based inhibition of rpoA offers a novel strategy to combat CDI by targeting essential gene expression.
  • This approach has the potential to disarm virulence factors and prevent recurrence without disrupting the gut microbiome.
Keywords:
C. difficilegut microflorapeptide nucleic acidsrpoAsporestoxinsvirulence factors

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.6K
A Purification and In Vitro Activity Assay for a pppGpp Synthetase from Clostridium difficile09:53

A Purification and In Vitro Activity Assay for a pppGpp Synthetase from Clostridium difficile

Published on: November 3, 2018

8.4K

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.1K
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.4K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
29.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K